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This year's Gruber Cosmology Prize -the most prestigious in the field -went to the European Space Agency's Planck satellite observatory team for its precise measurement of the Universe's contents and contours. The US$500,000 prize will be awarded on 20 August in Vienna. The Planck team has more than 300 members, of whom about one-fifth are women. Yet the collaboration has indicated that the team's half-share of the prize money (two principal investigators share the other half) would be divided between 43 senior members of the collaboration, all of whom are men. Although the number of recipients has to be limited and the prize money might end up being pooled, it is remarkable that this situation has arisen in 2018.
That all Planck's female scientists have even temporarily been deemed unworthy of controlling a share of the prize is unwelcome news, especially to the many of us trying to tackle the under-representation of women in astronomy. Olivier Berné Research Institute in Astrophysics and Planetology, University of Toulouse, France. olivier.berne@irap.omp.eu Speed up global ban on trans fats in foods I suggest that the food industry should be subject to a time limit for removing hazards identified in the global food system (see L. Haddad Nature 556, 19-22; 2018 We encourage other earlycareer scientists to engage in individual and group reviews, such as those organized by APECS, including the second review of the IPCC ocean and cryosphere report taking place later this year.
Expanding the reviewer pool in this way would benefit the scientific community by mitigating the review burden (see, for example, M. Kovanis et al. PLoS ONE 11, e0166387; 2016) . There would be career advantages for junior researchers who were accomplished reviewers. And they would gain insight into improving the preparation and presentation of their own papers.
Comprehensive reports such as those compiled by the IPCC provide a means for the scientific community to reach the public. Such engagement is becoming increasingly important, so earlycareer researchers must learn to contribute to it effectively. Heuer mentions some of the issues. For example, he foresees problems over whether to designate the algorithm or its programmer as the inventor, and whether a drug discovered through machine-learning methods would be patentable.
In the United States, at least, some of these issues are currently clear. For example, US patent law states that "a person shall be entitled to a patent", and an algorithm is not a person. It also states that "patentability shall not be negated by the manner in which the invention was made". More generally, it is insufficient to assert that just because an AI could arrive at a particular solution, then that solution must be obvious.
However, a serious problem for pharmaceutical companies is that, according to US law, only people can make the inventive step in patents. In practice, it is likely that algorithms are making many of those steps, raising questions about the validity of these patents in the United States. We welcome efforts to arrive at a consensus over such dilemmas by the robotics research community (see go.nature.com/2onhgcb), intellectual-property professionals (see go.nature. com/2oiwh4c), the European Commission and the European Patent Office. Ross D. King University of Manchester, UK.
